BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of nitric oxide
,
Phenobarbital
,
rs3825942
,
KLK3
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
idiopathic juxtafoveal telangiectasias
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Morphologic characteristics of idiopathic juxtafoveal telangiectasia using spectral-domain and polar…
A new vascular pattern for idiopathic juxtafoveal telangiectasia revealed by the retinal function im…
Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic…
Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to id…
Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Avastin in Juxtafoveal Telangiectasias
The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia …
Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal T…
Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ